Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
NCT04519476
Age 18 +
Sex Both
Phase Phase 1
Third Opinion Trial Synopsis
This study is checking if a drug called selinexor is safe and helpful for people with a type of cancer called multiple myeloma. The people in the study have already tried other treatments with a medicine called lenalidomide, but it didn't work well enough.
This study is checking if a drug called selinexor is safe and helpful for people with a type of cancer called multiple myeloma. The people in the study have already tried other treatments with a medicine called lenalidomide, but it didn't work well enough.
Third Opinion AI Generated Synopsis
Trial Summary
This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to lenalidomide-containing regimens with or without steroids.
This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to lenalidomide-containing regimens with or without steroids.
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
